GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hualan Biological Engineering Inc (SZSE:002007) » Definitions » Cyclically Adjusted FCF per Share

Hualan Biological Engineering (SZSE:002007) Cyclically Adjusted FCF per Share : ¥0.34 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Hualan Biological Engineering Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Hualan Biological Engineering's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥-0.033. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.34 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 6.50% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 6.40% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 13.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Hualan Biological Engineering was 21.90% per year. The lowest was 4.40% per year. And the median was 12.30% per year.

As of today (2024-06-09), Hualan Biological Engineering's current stock price is ¥17.79. Hualan Biological Engineering's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.34. Hualan Biological Engineering's Cyclically Adjusted Price-to-FCF of today is 52.32.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Hualan Biological Engineering was 227.11. The lowest was 50.37. And the median was 90.29.


Hualan Biological Engineering Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Hualan Biological Engineering's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hualan Biological Engineering Cyclically Adjusted FCF per Share Chart

Hualan Biological Engineering Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.29 0.29 0.32 0.33 0.35

Hualan Biological Engineering Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.34 0.33 0.35 0.34

Competitive Comparison of Hualan Biological Engineering's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Hualan Biological Engineering's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hualan Biological Engineering's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hualan Biological Engineering's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Hualan Biological Engineering's Cyclically Adjusted Price-to-FCF falls into.



Hualan Biological Engineering Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Hualan Biological Engineering's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.033/115.2271*115.2271
=-0.033

Current CPI (Mar. 2024) = 115.2271.

Hualan Biological Engineering Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.034 98.200 0.040
201409 0.047 98.900 0.055
201412 0.069 99.000 0.080
201503 0.000 99.900 0.000
201506 0.020 99.500 0.023
201509 0.064 100.500 0.073
201512 0.091 100.600 0.104
201603 -0.018 102.200 -0.020
201606 0.047 101.400 0.053
201609 -0.014 102.400 -0.016
201612 0.046 102.600 0.052
201703 -0.063 103.200 -0.070
201706 0.014 103.100 0.016
201709 0.002 104.100 0.002
201712 0.086 104.500 0.095
201803 -0.004 105.300 -0.004
201806 0.261 104.900 0.287
201809 0.233 106.600 0.252
201812 0.286 106.500 0.309
201903 0.076 107.700 0.081
201906 0.151 107.700 0.162
201909 0.086 109.800 0.090
201912 0.289 111.200 0.299
202003 0.001 112.300 0.001
202006 0.123 110.400 0.128
202009 -0.075 111.700 -0.077
202012 0.339 111.500 0.350
202103 0.034 112.662 0.035
202106 0.201 111.769 0.207
202109 -0.015 112.215 -0.015
202112 0.119 113.108 0.121
202203 -0.047 114.335 -0.047
202206 -0.029 114.558 -0.029
202209 0.029 115.339 0.029
202212 0.355 115.116 0.355
202303 0.102 115.116 0.102
202306 0.115 114.558 0.116
202309 -0.131 115.339 -0.131
202312 0.238 114.781 0.239
202403 -0.033 115.227 -0.033

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Hualan Biological Engineering  (SZSE:002007) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Hualan Biological Engineering's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=17.79/0.34
=52.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Hualan Biological Engineering was 227.11. The lowest was 50.37. And the median was 90.29.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Hualan Biological Engineering Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Hualan Biological Engineering's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Hualan Biological Engineering (SZSE:002007) Business Description

Traded in Other Exchanges
N/A
Address
No. A1 Hualan Avenue, Henan Province, Xinxiang, CHN, 453003
Hualan Biological Engineering Inc is a China-based biopharmaceutical company. It is engaged in the research, development, production, and commercialization of plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics. The plasma products offered by the company include Human albumin, Human fibrinogen, Human tetanus immunoglobulin and others. The vaccines products include Recombinant hepatitis B vaccine, Inactivated influenza vaccine and other. It also offers gene products such as Monoclonal Antibody for tumor, autoimmune diseases, infectious diseases, transplant rejection, and Recombinant monoclonal antibodies.
Executives
An Kang Directors, executives
Pan Ruo Wen Executives
An Wen Qi Executives
Wang Qi Ping Directors, executives
Fan Bei Directors, executives
Ma Xiao Wei Executives
Xie Jun Min Directors, executives
Zhang Bao Xian Executives
Lv Cheng Yu Securities Affairs Representative
Zhang Jin Gang Independent director
Wang Li Ting Independent director
Ma Li Supervisors
Sun Zhen Guo Supervisors
Chen Lei Shan Supervisors
Yang Bao Ping Supervisors

Hualan Biological Engineering (SZSE:002007) Headlines

No Headlines